MiR-378a inhibits glucose metabolism by suppressing GLUT1 in prostate cancer

Prostate cancer (PCa) is the fifth leading cause of cancer related deaths worldwide, in part due to a lack of molecular stratification tools that can distinguish primary tumours that will remain indolent from those that will metastasise. Amongst potential molecular biomarkers, microRNAs (miRs) have...

Descripción completa

Detalles Bibliográficos
Autores principales: Cannistraci, A., Hascoet, P., Ali, A., Mundra, P., Clarke, N. W., Pavet, V., Marais, R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897193/
https://www.ncbi.nlm.nih.gov/pubmed/35039635
http://dx.doi.org/10.1038/s41388-022-02178-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897193/
https://www.ncbi.nlm.nih.gov/pubmed/35039635
http://dx.doi.org/10.1038/s41388-022-02178-0

Ejemplares similares